Quarterly Activities/Appendix 4C Cash Flow Report

Open PDF
Stock Talius Group Ltd (TAL.ASX)
Release Time 27 Oct 2025, 10:16 a.m.
Price Sensitive Yes
 Talius Group Reports Quarterly Activities
Key Points
  • $4.0 million capital raise completed
  • Subscription numbers up 4% to 50,450
  • Revenue and other income of $1.8 million for the quarter
  • Strong commercial momentum with new customer orders
Full Summary

Talius Group Ltd (ASX: TAL) has reported its Q3 2025 results, highlighting a successful $4.0 million capital raise, continued growth in subscriptions, and strong commercial momentum with new customer orders. The company has secured binding commitments for a $4.0 million capital raise at $0.08 per share, which will meet its future capital needs. Subscription numbers have increased by 4% to over 50,450, with a further 11,000 subscriptions sold and awaiting activation. Revenue and other income for the quarter was $1.8 million, with delayed receipts of $0.5 million now booked in Q4. The company has continued to develop its operational framework with Wesco Anixter, advancing towards a scalable distribution model. The quarter also saw the receipt of $0.74 million in Research & Development tax concession for FY25. Talius has signed new contracts and received purchase orders from customers across the aged care, childcare, and gym sectors, demonstrating the scalability of its platform beyond traditional markets. The company is well-positioned to benefit from the new Aged Care Act commencing on 1 November 2025, which introduces the Support at Home program and funding for assistive technologies.

Guidance

Talius expects positive operating cash flow through Q4 and beyond. The company's annualised recurring subscription revenues remain strong at $3.3 million, representing a 4% increase on the previous quarter and a 36% increase on September 2024.

Outlook

Talius is focused on execution of strategy and pipeline, especially with the new Aged Care Act commencing on 1 November 2025. The company is well-capitalised and positioned to lead in the next phase of home care transformation, with significant opportunities emerging in adjacent healthcare markets.